Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(n/a)
# 4,361
Out of 4,818 analysts
3
Total ratings
n/a
Success rate
-55%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Dev Prasad

Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $4.95
Upside: +384.85%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $0.75
Upside: +700.00%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.52
Upside: +755.26%